Project Ambition

The MycoSynVac project aims at using cutting-edge synthetic biology methodologies to engineer Mycoplasma pneumoniae as a universal chassis for vaccination.

 

  • Prize for MycoSynVac poster at IOM 2018
  • Following our last two events this year in Linz and Bristol we held a final event for 2017 in Berlin, Germany on October 27. For this event we again...
  • Disease & Impact
  • Dr Carmen DE VICENTE COLL Research Programme Officer, European Commission
  • Infection caused by Mycoplasma species on livestock result in multi-million losses in Europe and USA
  • Current production processes of vaccines based on mycoplasma are very irreproducible and prone to contamination by animal viruses.